Biomedical problem is not universal, no need to create a sensational social effects. The key biomedical technology, research and technology is the elite few can do something. Research in the study of elites need a quiet room to reasoning in clinical quietly argument. Will open some eyes again, the need to train more university biotechnology research personnel, the need is the introduction of top international experts and mentors.

Biomedical technology with the rise of heat in the world, the Chinese government in recent years, this degree of attention and support is also growing. Pursuit of capital market coupled with strong domestic bio-medical technology is opening a blueprint for a better future. But calm down and think about the domestic R & D and technology in the biomedical aspects of policy support should be to prevent the cart before the horse situation.
 With life science theory, in research and development,and by the end of the guard house, the use of organisms and cellular and molecular structu ral changes, combined with engineering, information science and other means of making medicine of the Chinese nation for thousands of years the number of first use of drugs, ways to treat disease, longevity of the basic logic, the current , the Western medical theories, medical bio-technology.
  Chinese medicine theory and compared to Western medicine in the drug target and focus more on understanding the global light. Medical concepts in biotechnology, the proposed "use life science based on the theory", the use of "organism", "combined with engineering" and other means of Western principles and a step forward in understanding. This progress in the understanding of Western medicine does not mean that what is on the initiative, but it can break through the previous knowledge of the narrow, traditional Chinese medicine into the overall understanding of the concept track. As one of the greatest living cosmologist Hawking expounded "the universe from without" into Lao Tzu's "born of no" knowledge of the same track.
  However, in research practice, but often return to the Western medical theory of the old chemical drug targeting, gene said protein, said point monoclonal antibodies and other targeted therapy theory, research sucked into the endless multitude of screening , and from one another in search of a negative affirmation from the mountain is another mountain path to the convention to explore new knowledge of technology, time and money spent decades and billions of dollars to design, the conclusions back to the clinical reality exchange is often disappointing. Thus, biotechnology has been branded a "high investment, high risk, high-cycle" of the brand, but difficult to cast a difficult, somewhat esoteric mystery coat.
  In fact, the path of modern biotechnology R & D is working with the philosophy of traditional Chinese medical theory and the same thing. The success of the vaccine should be given to biotechnology research revealed that this "fire with fire" Philosophy is also the source of the wisdom of traditional Chinese medicine.
  As a born and bred, Ru Yang of China in Sri Lanka biotech researchers, if we neglect the wisdom of traditional medicine culture and philosophy of the guidelines, death chase out the Western biotechnology research path, indulge in endless screening point , is likely to be forest for the trees, looking for horse riding, has been long abandoned and incorporated short; if contemporary art biotechnology as a means to try traditional Chinese medicine from philosophy in search of inspiration, with the results speak, and create with Chinese characteristics biomedical R & D of the path, or may rely on to get rid of a large investment, the old orders in luck, and out of a shortcut to biomedical technology.
  In the policy support, the emphasis should be avoided and light the end. In recent years, China's biotech pharmaceutical industry and gradually formed a "little" phenomenon: biomedical technology, many enterprises, biotechnology, pharmaceutical R & D institutions and more, bio-medical technology industrial park and industrial base more; but the real value of support research projects are small, hard to find.
There are billions of national innovation fund support, the local government the importance of biotechnology, many pharmaceutical companies have to move closer to the biotechnology industry. From that number, enough to boost China's leading bio-pharmaceutical companies the confidence of the world, but really only a handful in biomedical research, it is possible to provide a breakthrough treatment in the future, I am afraid is very few. Application information from clinical studies, in addition to imitation or imitation, the real small number of independent innovation, and on another breakthrough in the treatment of the possible is even more rare.
  A national strategic importance, there is local government's pursuit of performance; the top biotechnology companies dare to medicine hat, there is the government building the basis for the biotechnology industry park. As a result, large tracts of biotechnology industrial park in the country such as the post road truck pear, though not even the point into the surface, but enough to be seen everywhere along the highway landscape.
Biotechnology, pharmaceutical development must be a pyramid: a small number of winners below, have a large number of founders. In other words, pharmaceutical companies engaged in biotechnology more, more scientific research institutions, industrial park, the more you should be able to promote the achievements of more biotech medicine Pearl. The problem is, these are really the founders of the founders or pseudo-founders? Whether the enterprise has been paving the way in bio-medicine? R & D institutions are doing fly in the biological field research? Accordingly, the so-called support is genuine innovation in biotechnology research and application? If you are in the guise of the name of biomedical technologies, as to attract funds, recruitment policies to support the promoter, bio-technology medicine may become a burst of dancing flames in the wind, burnt no less than what got left scratch.
  Over the years, biotechnology gives aspirations to meet the treatment expectations or very few. Those already on the market, there are some effects and side effects remain controversial; even have been a number of generic varieties, and some are "The Emperor's New Clothes." In the study of the concept, which is the real worth of seed it? State and local governments in support of biomedical, what kind of standards that, what kind of rating agencies, to identify those who actually go to support the cultivation of the seeds? Screening potential targets, than the luxurious parks and huge amount of money is more real.
  Biomedical problem is not universal, no need to create a sensational social effects. The key biomedical technology, research and technology is the elite few can do something. Research in the study of elites need a quiet room to reasoning, in clinical quietly argument. Will open some eyes again, the need to train more university biotechnology research personnel, the need is the introduction of top international experts and mentors. Biotechnology and support policies do not focus on project selection, and interested in biomedical park construction projects reported vague concept of the enterprise, it may be that the support of biomedical policy and funding as the demons coveted official told us. On the global competition in biotechnology medicine point of view, was a dearth of research funding for the Chinese bio-pharmaceutical industry, to support policy implementation easy road is not only heavy and light at the end of this issue, or self-deception. (From Medicine Economic News)